GHK-Cu questions
The small naming questions turn out to be consequential. I want the molecule and the route settled before a large claim gets attached to either.
What is copper peptide?
A copper peptide is a short amino-acid chain that binds copper. GHK-Cu contains glycine, histidine and lysine with copper; Copper Tripeptide-1 is its cosmetic ingredient name. The skin-regeneration review covers its biology and topical history.
Did the mouse memory studies use GHK-Cu?
They used free GHK, given intranasally. The aged-mouse preprint and 5xFAD preprint reported improvements in maze performance. The copper-bound form has to earn its own neurological evidence. This distinction was the first loose thread I wanted to pull.
Does GHK-Cu reach the brain?
The intranasal mouse work does not answer that in humans. Nasal delivery offers an alternative access route to the brain, and the nerve-cell experiment applied free GHK directly to cultures. Human distribution measurements remain missing.
Does GHK-Cu increase collagen?
In cultured human fibroblasts, it increased collagen synthesis without changing cell number. The skin review also describes small topical human studies. I am comfortable describing those specific observations; whole-body rejuvenation would require much more.
Hair-growth timing
The combination trial measured hair-count changes at six months. It gives no validated earlier onset interval and tested GHK with another active ingredient. Community accounts of less shedding and thicker-looking hair are anecdotal, not clinical evidence. The hair page examines those accounts alongside the trial.
Is copper peptide safe?
The human topical literature provides a small and route-specific record. Skin irritation and pigment changes remain concerns; validated human systemic safety and pharmacokinetic data are lacking. A safety claim without a route or preparation attached leaves the practical question unanswered.
Gene tallies
The 2018 analysis reports about 2,100 genes at its threshold of a change of at least 50%. The familiar '~4,000 genes' claim is an extrapolation beyond that table. Much of the work came from gene-expression databases and awaits protein-level validation in living systems. A gene count alone cannot establish a clinical benefit.
Is GHK-Cu approved as a drug?
GHK-Cu has no FDA- or EMA-approved therapeutic indication. Copper Tripeptide-1 is permitted as a cosmetic ingredient in the US, EU and UK. Cosmetic use gives an ingredient a particular role; it confers no drug approval. The research amounts here establish no human treatment instructions.